These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 25534164)
1. Serum endocan concentration in women with pre-eclampsia. Yuksel MA; Tuten A; Oncul M; Acikgoz AS; Temel Yuksel I; Toprak MS; Ekmekci H; Balci Ekmekci O; Madazli R Arch Gynecol Obstet; 2015 Jul; 292(1):69-73. PubMed ID: 25534164 [TBL] [Abstract][Full Text] [Related]
2. Serum levels of endocan correlate with the presence and severity of pre-eclampsia. Cakmak M; Yilmaz H; Bağlar E; Darcin T; Inan O; Aktas A; Celik HT; Ozdemir O; Atalay CR; Akcay A Clin Exp Hypertens; 2016; 38(2):137-42. PubMed ID: 26418319 [TBL] [Abstract][Full Text] [Related]
3. Alteration of serum endocan in normal pregnancy and preeclampsia. Wang HZ; Jin Y; Wang P; Han C; Wang ZP; Dong MY Clin Exp Obstet Gynecol; 2017; 44(3):419-422. PubMed ID: 29949285 [TBL] [Abstract][Full Text] [Related]
4. Endocan-1 concentrations in maternal and fetal plasma and placentae in pre-eclampsia in the third trimester of pregnancy. Hentschke MR; Lucas LS; Mistry HD; Pinheiro da Costa BE; Poli-de-Figueiredo CE Cytokine; 2015 Jul; 74(1):152-6. PubMed ID: 25957465 [TBL] [Abstract][Full Text] [Related]
5. Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes. Adekola H; Romero R; Chaemsaithong P; Korzeniewski SJ; Dong Z; Yeo L; Hassan SS; Chaiworapongsa T J Matern Fetal Neonatal Med; 2015; 28(14):1621-32. PubMed ID: 25211383 [TBL] [Abstract][Full Text] [Related]
6. Serum endocan concentration and its correlation with severity of hypertensive disorders in pregnancy. Szpera-Goździewicz A; Kosicka K; Goździewicz T; Krzyścin M; Wirstlein P; Siemiątkowska A; Główka FK; Wender-Ożegowska E; Markwitz W; Bręborowicz GH J Matern Fetal Neonatal Med; 2020 Jul; 33(14):2313-2319. PubMed ID: 30501553 [No Abstract] [Full Text] [Related]
8. Maternal serum endocan concentrations are elevated in patients with preterm premature rupture of membranes. Ovayolu A; Ovayolu G; Karaman E; Yuce T; Turgut A; Bostancıeri N J Perinat Med; 2019 Jul; 47(5):510-515. PubMed ID: 30875331 [TBL] [Abstract][Full Text] [Related]
9. Endocan of the maternal placenta tissue is increased in pre-eclampsia. Chang X; Bian Y; Wu Y; Huang Y; Wang K; Duan T Int J Clin Exp Pathol; 2015; 8(11):14733-40. PubMed ID: 26823798 [TBL] [Abstract][Full Text] [Related]
10. Changes in endothelial cell specific molecule 1 plasma levels during preeclamptic pregnancies compared to healthy pregnancies. Schuitemaker JHN; Cremers TIFH; Van Pampus MG; Scherjon SA; Faas MM Pregnancy Hypertens; 2018 Apr; 12():58-64. PubMed ID: 29674200 [TBL] [Abstract][Full Text] [Related]
11. Circulating endocan and preeclampsia: a meta-analysis. Lan X; Liu Z Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31854443 [TBL] [Abstract][Full Text] [Related]
12. Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia. Yu J; Shixia CZ; Wu Y; Duan T Ultrasound Obstet Gynecol; 2011 May; 37(5):528-33. PubMed ID: 20737451 [TBL] [Abstract][Full Text] [Related]
13. The relationship between brachial artery flow-mediated dilatation, high sensitivity C-reactive protein, and uterine artery doppler velocimetry in women with pre-eclampsia. Adali E; Kurdoglu M; Adali F; Cim N; Yildizhan R; Kolusari A J Clin Ultrasound; 2011 May; 39(4):191-7. PubMed ID: 21480285 [TBL] [Abstract][Full Text] [Related]
14. Does endocan level increase in women with polycystic ovary syndrome? A case - control study. Delibas IB; Yapca OE; Laloglu E Ginekol Pol; 2018; 89(9):500-505. PubMed ID: 30318577 [TBL] [Abstract][Full Text] [Related]
15. Negative Correlation between Placental Growth Factor and Endocan-1 in Women with Preeclampsia. Hentschke MR; da Cunha Filho EV; Vieira MC; Paula LG; Mistry HD; Costa BEPD; Poli-de-Figueiredo CE Rev Bras Ginecol Obstet; 2018 Oct; 40(10):593-598. PubMed ID: 30352456 [TBL] [Abstract][Full Text] [Related]
16. Maternal serum endothelial cell-specific molecule-1 level and its correlation with severity of early-onset preeclampsia. Ovayolu A; Karaman E; Turgut A; Guler S; Bostancieri N J Obstet Gynaecol; 2021 Aug; 41(6):893-898. PubMed ID: 33228435 [TBL] [Abstract][Full Text] [Related]
17. Assessment of angiogenesis modulators in pregnant women with pre-eclampsia: a case-control study. Mundim GJ; Paschoini MC; Araujo Júnior E; Da Silva Costa F; Rodrigues Júnior V Arch Gynecol Obstet; 2016 Feb; 293(2):369-75. PubMed ID: 26205065 [TBL] [Abstract][Full Text] [Related]
18. Endocan as a predictor of increased cardiovascular risk during the menopausal transition period. Yıldız Ş; Kaya C; Gedikbaşı A; Cengiz H; Alay İ; Öztürk E; Tunca AF; Yaşar L Arch Gynecol Obstet; 2020 Jun; 301(6):1553-1560. PubMed ID: 32270331 [TBL] [Abstract][Full Text] [Related]
19. Serum visfatin levels in late pregnancy and pre-eclampsia. Hu W; Wang Z; Wang H; Huang H; Dong M Acta Obstet Gynecol Scand; 2008; 87(4):413-8. PubMed ID: 18382866 [TBL] [Abstract][Full Text] [Related]
20. Endocan is a predictor of increased cardiovascular risk in women with polycystic ovary syndrome. Bicer M; Guler A; Unal Kocabas G; Imamoglu C; Baloglu A; Bilgir O; Yuksel A; Bozkaya G; Calan M Endocr Res; 2017 May; 42(2):145-153. PubMed ID: 27911121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]